The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1a/b study of BR101801, a PI3Kγδ and DNA PK triple inhibitor, in adult patients with advanced hematologic malignancies.
 
Bong-Seog Kim
Employment - Boryung; Recuon
Leadership - Recuon
 
Seok Jin Kim
No Relationships to Disclose
 
Tae Min Kim
Consulting or Advisory Role - AstraZeneca/MedImmune; Janssen Oncology; Novartis; Regeneron; Samsung Bioepis; Takeda; Yuhan
Speakers' Bureau - IMBdx; Janssen Research & Development; Takeda
Research Funding - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca/MedImmune; Boryung; Novartis; Roche/Genentech
 
Dok Hyun Yoon
Honoraria - Amgen; Celgene; Celltrion; Janssen; Kirin Pharmaceuticals; Roche; Samyang; Takeda
Consulting or Advisory Role - ABclonal; Amgen; Celgene; GC Pharma; Janssen; Novartis; Roche
Research Funding - ABclonal; Amgen; Boryung; Eutilex; Genmab; Janssen Oncology; Roche/Genentech; Samyang
 
Jin Seok Kim
No Relationships to Disclose
 
Eunyoung Lee
No Relationships to Disclose
 
Won-Sik Lee
No Relationships to Disclose
 
Jeong-Ok Lee
No Relationships to Disclose
 
Deok-Hwan Yang
No Relationships to Disclose